Health Economics & Outcomes Research

In today’s markets, pharmaceutical, biotechnology, and medical device &
diagnostics companies must approach every business decision
strategically, with data to support every move.

Health Economics & Outcomes Research

In today’s markets, pharmaceutical, biotechnology, and medical device &
diagnostics companies must approach every business decision
strategically, with data to support every move.

“Our clients save lives and improve the health of communities around the world. Stage Analytics strives to develop the best HEOR evidence and analytical solutions that demonstrate the value and ensure patient access to life-saving therapies all over the world.”

Vasco Pontinha, MPharm, MBA, PhD Director, Health Economics & Outcomes Research

Stage Analytics™

Strategize, Generate, and Communicate Value

At Stage Analytics, our health economics & outcomes research (HEOR) services help clients develop, support, and communicate the value of their innovations – throughout the entire product development process. From the very early clinical development stages to post-approval and market access phases, we are your partner to strategize and support your evidence generation efforts at every stage of the journey. 

Our clients operate in the following industries:

Demonstrate value.
Gain market access.

The Stage Analytics™ Difference

At Stage Analytics, we help our clients reach their unique research, commercial, and market access goals through our customized health economics & outcomes research (HEOR) solutions. We combine scientific and academic rigor with personalized project management services to generate credible, fit-for-purpose deliverables that bring significant value to our clients. Our epidemiologic, economic, and outcomes research capabilities employ advanced methods and clinical expertise to effectively and reliably communicate product value to payers, HTA agencies, healthcare organizations, providers, and other key stakeholders.

Pre-approval

Phase 1 - Phase 3

Strategic Evidence Generation Plans

Phase 1 - Phase 3

Burden of Illness and cost of illness studies

Phase 1 - Phase 2

Early cost-effectiveness modeling and scenario analysis​

Phase 1 - Phase 2

Quantification of market size and unmet medical need

Phase 2 - Phase 3

Identification of outcome research endpoints​

Phase 2 - Phase 3

Cost-effectiveness analysis alongside clinical trials

Phase 3

Patient-reported outcomes

Phase 4

Support for ICER and HTA reviews

Phase 4

Budget impact models

Phase 4

Economic evaluation

Phase 4

Real-world evidence generation plans

Phase 4

Real-world evidence studies

Phase 4

Payer engagement support

Post-approval

Phase 4

Strategic Evidence Generation Plans

Phase 4

Burden of Illness and cost of illness studies

Phase 4

Patient-reported outcomes

Phase 4

Support for ICER and HTA reviews

Phase 4

Budget impact models

Phase 4

Economic evaluation

Phase 4

Real-world evidence generation plans

Phase 4

Real-world evidence studies

Phase 4

Payer engagement support

Our HEOR services include but are not limited to:

Pre-approval

Post-approval

Strategic evidence generation plans
Burden of Illness and cost of illness studies
Early cost-effectiveness modeling and scenario analysis
Quantification of market size and unmet medical need
Identification of outcome research endpoints​
Cost-effectiveness analysis alongside clinical trials
Patient-reported outcomes
Support for ICER and HTA reviews
Budget impact models
Economic evaluation
Real-world evidence generation plans
Real-world evidence studies
Payer engagement support

Get industry insights and Stage Analytics™ news in your inbox!

Sign up for our monthly email newsletter.

Stage Analytics
Stage Analytics

Get industry insights and Stage Analytics news in your inbox!

Sign up for our monthly email newsletter.

Skip to content